Venue: Rhodes, Greece.
The 3rd ACTC meeting is focused on “Liquid Biopsy in clinical practice” by bringing together researchers and clinicians to discuss practical implementation of CTCs and ctDNA and translate much of the excellent basic research in this field into clinical practice. The most prominent and established researchers in the field will present state of the art research on the technical advancements in the isolation, and detection of CTCs and ctDNA, as well as on the potential of Liquid Biopsy analysis in clinical practice. Latest findings on the clinical applications of CTCs, ctDNA, miRNAs and exosomes in real time monitoring of systemic anticancer therapies will be discussed. Many leading professionals in the Liquid Biopsy field have already confirmed their participation in ACTC 2017.
More information on the conference website.